Increases effect of anticoagulants & may cause excessive hypoprothrombinemia & bleeding. May increase levels of phenytoin. Enhanced metabolism of thyroid hormones & possible displacement from plasma proteins w/ carbamazepine & phenytoin. Cardiac glycosides. Enhanced effects of sympathomimetic agents. Increased receptor sensitivity to catecholamines thus accelerating response to TCAs. Reduced GI absorption w/ cholestyramine. Decreased absorption w/ bile acid sequestrants (eg, colestipol), anion/cation exchange resins (eg, kayexalate, sevelamer), sucralfate, Ca carbonate, & ferrous sulfate. Increased serum conc of thyroxine-binding globulin w/ OC, estrogen, tamoxifen, clofibrate, methadone, & 5-fluorouracil. May increase thyroid hormone requirements w/ HMG-CoA reductase inhibitors (statins). Decreased serum conc of thyroxine-binding globulin w/ androgens & anabolic steroids. Increased levothyroxine Na dosage requirements in hypothyroid patients when used w/ tyrosine kinase inhibitors (eg, imatinib & sunitinib), & amiodarone. Large doses w/ diet pills may cause symptoms of toxicity.